Trials / Completed
CompletedNCT04957745
Understanding Visual Confusion Using Stereoscopic Displays
Monocular Visual Confusion for Field Expansion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Massachusetts Eye and Ear Infirmary · Academic / Other
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Accepted
Summary
In this research study we want to test how people understand a visual scene when the same image is presented to both the eyes, but portions of these images are altered in terms of contrast, depth or in some cases motion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Binocular visual confusion (unilateral opaque) | The peripheral target was a horizontally drifting grating measuring 10° by 10°, with a spatial frequency of 1 cycle per degree and a temporal frequency of 3 Hz, and located at 10° above the fixation. For the binocular visual confusion condition, the non-transparent (opaque) peripheral target will be displayed on only one eye (unilateral opaque display). |
| BEHAVIORAL | Unilateral monocular visual confusion (unilateral see-through) | The peripheral target was a horizontally drifting grating measuring 10° by 10°, with a spatial frequency of 1 cycle per degree and a temporal frequency of 3 Hz, and located at 10° above the fixation. For the unilateral monocular visual confusion condition, the half-transparent peripheral target will be displayed on only one eye (unilateral see-through display). |
| BEHAVIORAL | Bilateral monocular visual confusion (bilateral see-through) | The peripheral target was a horizontally drifting grating measuring 10° by 10°, with a spatial frequency of 1 cycle per degree and a temporal frequency of 3 Hz, and located at 10° above the fixation. For bilateral monocular visual confusion condition, the half-transparent peripheral target will be displayed on both eyes (bilateral see-through display). |
Timeline
- Start date
- 2021-11-09
- Primary completion
- 2022-07-27
- Completion
- 2022-07-27
- First posted
- 2021-07-12
- Last updated
- 2023-07-10
- Results posted
- 2023-07-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04957745. Inclusion in this directory is not an endorsement.